Valuation: GC Corp.

Market Cap 43TCr 31Cr 28Cr 26Cr 24Cr 45Cr 3.02TCr 45Cr 313.4Cr 121.45Cr 1.54TCr 118.26Cr 115.69Cr 5.01TCr P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,82500Cr 133.32Cr 117.27Cr 110.55Cr 100.86Cr 188.62Cr 13TCr 190.09Cr 1.33TCr 514.08Cr 6.51TCr 500.57Cr 489.71Cr 21TCr EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
1 day-0.84%
1 week-2.58%
Current month-5.88%
1 month-8.35%
3 months-7.63%
6 months-31.74%
Current year-40.70%
1 week 9,400
Extreme 9400
9,700
1 month 9,380
Extreme 9380
11,470
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
34,000
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2010
Chief Executive Officer 72 25/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 17/12/2010
Director/Board Member 76 01/03/2009
Director/Board Member 52 01/03/2010
Date Insider Type Main position Quantity % Market Cap. Importance
25/04/25 Buy

Chief Executive Officer

1,334 0.0028%
25/04/25 Buy

Chief Executive Officer

3,191 0.0068%
25/04/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-2.58%-42.44%-34.85% 32Cr
+2.68%+2.56%+59.32%+114.68% 1,02600Cr
+0.56%+0.17%+53.19%+68.65% 65TCr
+0.02%+0.42%+20.51%+73.58% 47TCr
+0.06%+0.61%+39.82%+45.71% 35TCr
+1.16%+2.53%+21.60%+29.39% 27TCr
-0.24%-0.23%+10.62%+12.26% 26TCr
-0.01%+6.91%+45.42%+51.68% 22TCr
-1.11%-0.80%+31.69%+99.56% 19TCr
+0.30%-9.43%-31.91%-60.56% 17TCr
Average -0.01%+0.21%+20.78%+40.01% 35.99TCr
Weighted average by Cap. +0.12%+1.06%+38.35%+67.67%

Financials

2024 2025
Net sales 2,20500Cr 161.05Cr 141.66Cr 133.54Cr 121.84Cr 227.86Cr 15TCr 229.63Cr 1.6TCr 621.01Cr 7.87TCr 604.7Cr 591.57Cr 26TCr 2,45100Cr 179.07Cr 157.51Cr 148.48Cr 135.47Cr 253.34Cr 17TCr 255.32Cr 1.78TCr 690.47Cr 8.75TCr 672.33Cr 657.74Cr 28TCr
Net income 2.4TCr 1.75Cr 1.54Cr 1.46Cr 1.33Cr 2.48Cr 168.46Cr 2.5Cr 17Cr 6.77Cr 86Cr 6.59Cr 6.45Cr 279Cr -6.95TCr -5.08Cr -4.47Cr -4.21Cr -3.84Cr -7.18Cr -487.41Cr -7.24Cr -51Cr -20Cr -248.07Cr -19Cr -19Cr -807.23Cr
Net Debt 1,04200Cr 76Cr 67Cr 63Cr 58Cr 107.69Cr 7.31TCr 108.53Cr 757.38Cr 293.49Cr 3.72TCr 285.78Cr 279.58Cr 12TCr 1,39400Cr 101.83Cr 90Cr 84Cr 77Cr 144.06Cr 9.77TCr 145.18Cr 1.01TCr 392.63Cr 4.97TCr 382.32Cr 374.02Cr 16TCr
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
23/26/23 ₩9,440.00 -0.84% 31,614
22/26/22 ₩9,520.00 -1.04% 33,365
21/26/21 ₩9,620.00 +0.73% 40,239
18/26/18 ₩9,550.00 -1.44% 37,239
17/26/17 ₩9,690.00 +2.32% 71,271
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock